Skip to content

EDGAR Index

SEC Filing News

Asset 2 728x90 Blue
Primary Menu

EDGAR Index

  • Insider Trading
  • Mergers & Acquisitions
  • Market Outlook
    • Earnings Reports
  • Securities & Exchange
  • Class Action Lawsuits
  • Securities Litigation
    • Market Manipulation
    • Securities Fraud
  • Home
  • 2025
  • September
  • 21
  • Galmed Pharmaceuticals schedules annual general meeting for October 28
  • SEC Filing

Galmed Pharmaceuticals schedules annual general meeting for October 28

September 21, 2025

Enable JavaScript and cookies to continue

Post Navigation

Previous $DYNT Earnings Preview: Recent $DYNT Insider Trading, Hedge Fund Activity, and More
Next Senate Democrats Call for Fast Bipartisan Action on CLARITY Act Bill – CoinCentral

Recent Posts

  • Success for healthcare leaders in 2026 will be defined by safely scaling AI.
  • Organ Procurement Overview and Updates for Payers, Providers, and Patients
  • What Caused Lumentum’s (LITE) 46.2% Increase Since Last Earnings Report?
  • The fallacy at the heart of prediction markets
  • Senators suggest prohibiting US government officials from participating in prediction market trading
Coinbase 480x320

Recent Comments

No comments to show.

Archives

  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • July 2024
  • June 2024

Catgories

  • 10-K – Annual Reports
  • Class Action Lawsuits
  • Earnings Reports
  • Insider Trading
  • Market Manipulation
  • Market Outlook
  • Mergers & Acquisitions
  • SEC Filing
  • SEC Filings
  • Securities & Exchange
  • Securities Fraud
  • Securities Litigation
Copyright ©2001-2024 All rights reserved. | CoverNews by AF themes.